182 related articles for article (PubMed ID: 19816027)
1. Impact of first-trimester aneuploidy screening in a high-risk population.
Nadel AS; Likhite ML
Fetal Diagn Ther; 2009; 26(1):29-34. PubMed ID: 19816027
[TBL] [Abstract][Full Text] [Related]
2. Uptake of noninvasive prenatal testing at a large academic referral center.
Larion S; Warsof SL; Romary L; Mlynarczyk M; Peleg D; Abuhamad AZ
Am J Obstet Gynecol; 2014 Dec; 211(6):651.e1-7. PubMed ID: 24954652
[TBL] [Abstract][Full Text] [Related]
3. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
4. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
Chasen ST; McCullough LB; Chervenak FA
Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
[TBL] [Abstract][Full Text] [Related]
5. First trimester contingent testing with either nuchal translucency or cell-free DNA. Cost efficiency and the role of ultrasound dating.
Conner P; Gustafsson S; Kublickas M
Acta Obstet Gynecol Scand; 2015 Apr; 94(4):368-75. PubMed ID: 25581307
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of noninvasive prenatal diagnosis using cell free fetal DNA in maternal plasma].
Hou QF; Wu D; Chu Y; Kang B; Liao SX; Yang YL; Zhang CY; Zhang JX; Wu G
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):813-7. PubMed ID: 23302120
[TBL] [Abstract][Full Text] [Related]
7. The impact of utilization of early aneuploidy screening on amniocenteses available for training in obstetrics and fetal medicine.
Rose NC; Lagrave D; Hafen B; Jackson M
Prenat Diagn; 2013 Mar; 33(3):242-4. PubMed ID: 23354826
[TBL] [Abstract][Full Text] [Related]
8. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
Spencer K; Spencer CE; Power M; Dawson C; Nicolaides KH
BJOG; 2003 Mar; 110(3):281-6. PubMed ID: 12628268
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis for detection of aneuploidy: the options.
Budorick NE; O'Boyle MK
Radiol Clin North Am; 2003 Jul; 41(4):695-708. PubMed ID: 12899486
[TBL] [Abstract][Full Text] [Related]
10. Beyond the first trimester screen: can we predict who will choose invasive testing?
van Landingham S; Bienstock J; Wood Denne E; Hueppchen N
Genet Med; 2011 Jun; 13(6):539-44. PubMed ID: 21415760
[TBL] [Abstract][Full Text] [Related]
11. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
Sharda S; Phadke SR
J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
[TBL] [Abstract][Full Text] [Related]
12. Screening for aneuploidies by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-13+6 gestational weeks.
Karadzov-Orlić N; Egić A; Filimonović D; Marinković M; Damnjanović-Pazin B; Milovanović Z; Joksić I; Branković S; Lukić R; Mandić V; Cerović N; Mojović D; Plamenac S; Stanković M; Maglić D; Mikovć Z
Srp Arh Celok Lek; 2012; 140(9-10):606-11. PubMed ID: 23289277
[TBL] [Abstract][Full Text] [Related]
13. Do we need readjustment of the biochemical parameters in first trimester combined aneuploidy screening test in women with polycystic ovary syndrome?
Karsli MF; Gultekin IB; Cakmak B; Yeral MI; Seckin KD; Alt Nboga O; Kucukozkan T
Prenat Diagn; 2014 Nov; 34(11):1073-6. PubMed ID: 24916516
[TBL] [Abstract][Full Text] [Related]
14. First-trimester and second-trimester screening at a community hospital: experience from the first year of implementation.
Philipson EH; Callahan M; Jelovsek JE
Obstet Gynecol; 2008 Aug; 112(2 Pt 1):218-22. PubMed ID: 18669714
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of first-trimester aneuploidy screening in a United States population can replicate data from clinical trials.
Perni SC; Predanic M; Kalish RB; Chervenak FA; Chasen ST
Am J Obstet Gynecol; 2006 Jan; 194(1):127-30. PubMed ID: 16389021
[TBL] [Abstract][Full Text] [Related]
16. Congenital diaphragmatic hernia in a first-trimester ultrasound aneuploidy screening program.
Sepulveda W; Wong AE; Casasbuenas A; Solari A; Alcalde JL
Prenat Diagn; 2008 Jun; 28(6):531-4. PubMed ID: 18509856
[TBL] [Abstract][Full Text] [Related]
17. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
[TBL] [Abstract][Full Text] [Related]
18. Fetal karyotyping after 28 weeks of gestation for late ultrasound findings in a low risk population.
Drummond CL; Gomes DM; Senat MV; Audibert F; Dorion A; Ville Y
Prenat Diagn; 2003 Dec; 23(13):1068-72. PubMed ID: 14691994
[TBL] [Abstract][Full Text] [Related]
19. First- and second-trimester screening: detection of aneuploidies other than Down syndrome.
Breathnach FM; Malone FD; Lambert-Messerlian G; Cuckle HS; Porter TF; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Klugman S; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Tripp T; Bianchi DW; D'Alton ME;
Obstet Gynecol; 2007 Sep; 110(3):651-7. PubMed ID: 17766613
[TBL] [Abstract][Full Text] [Related]
20. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
Friel LA; Czerwinski JL; Singletary CN
Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
